<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                               NIH Public Access <br />                                Author Manuscript <br />                                Circulation. Author manuscript; available PMC 2014 April 28. <br />                            Published final edited form  <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             Circulation. 2009 November 10; 120(19): 1883&#226;&#8364;&#8220;1892. doi:10.1161/CIRCULATIONAHA.108.837724. <br />  <br />  <br />  <br />                            Glycome Transcriptome Regulation Vasculogenesis <br />                            Rania Harfouche, PhD#, Dirk M. Hentschel, MD#, Stephanie Piecewicz, BS#, Sudipta Basu, <br />                            PhD, Cristin Print, MBChB, PhD, David Eavarone, BS, Tanyel Kiziltepe, PhD, Ram <br />                            Sasisekharan, PhD, Shiladitya Sengupta, PhD <br />                            Department Medicine (R.H., D.M.H., S.P., S.B., S.S.), Brigham Women&apos;s Hospital, Boston, <br />                            Mass; Department Molecular Medicine Pathology (C.P.), University Auckland, Auckland, <br />                            New Zealand; Department Biological Engineering (D.E., T.K., R.S.), Massachusetts Institute                            Technology, Cambridge, Mass; Harvard-MIT Division Health Sciences Technology <br />                            (R.H., S.P., S.B., D.E., T.K., R.S., S.S.), Cambridge, Mass. <br />                            #   authors contributed equally work. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                            Abstract <br />                                  Background&#226;&#8364;&#8221;Therapeutic vasculogenesis emerging concept potentially                                  harnessed management ischemic pathologies. present study elucidates potential <br />                                  coregulation vasculogenesis heparan sulfate glycosaminoglycan&#226;&#8364;&#8220;rich cell-surface <br />                                  glycome transcriptome. <br />  <br />                                  Methods Results&#226;&#8364;&#8221;Differentiation embryonic stem cells endothelial cells                                  vitro embryoid body paralleled amplification heparan sulfate glycosaminoglycan <br />                                  sulfation, correlates levels enzyme N-deacetylase/N-sulfotransferase 1 <br />                                  (NDST1). Small hairpin RNA&#226;&#8364;&#8220;mediated knockdown NDST1 modification heparan sulfate <br />                                  glycosaminoglycans embryonic stem cells heparinases sodium chlorate inhibited <br />                                  differentiation embryonic stem cells endothelial cells. translated vivo <br />                                  zebrafish embryo model, genetic knockdown NDST1 resulted impaired <br />                                  vascularization characterized concentration-dependent decrease intersegmental vessel <br />                                  lumen large tail-vessel configuration, rescued use exogenous sulfated <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                  heparan sulfate glycosaminoglycans. explore cross talk glycome                                  transcriptome vasculogenesis, identified microarray validated wild-type <br />                                  NDST1 knockdown&#226;&#8364;&#8220;associated gene-expression patterns zebrafish embryos. Temporal <br />                                  analysis 3 developmental stages critical vasculogenesis revealed cascade pathways                                  mediate glycocalyx regulation vasculogenesis. pathways intimately connected <br />                                  cell signaling, cell survival, cell fate determination. Specifically, demonstrated                                  forkhead box O3A/5 proteins insulin-like growth factor key downstream signals                                  process. <br />  <br />  <br />  <br />                            &#194;&#169; 2009 American Heart Association,  <br />                            Correspondence Dirk M. Hentschel Shiladitya Sengupta, Room 317, 65 Landsdowne St, Cambridge, MA 02139. <br />                            shiladit@mit.edu dhentschel@partners.org. <br />                            online Data Supplement available article http://circ.ahajournals.org/cgi/content CIRCULATIONAHA. <br />                            108.837724/DC1. Guest Editor article Daniel  Simon, MD. <br />                            Disclosures <br />                             Harfouche et al.                                                                                             Page 2 <br />  <br />  <br />                                     Conclusions present study time implicates interplay glycome                                     transcriptome vasculogenesis, revealing possibility harnessing specific cellular <br />                                     glyco-microenvironments therapeutic vascularization. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Keywords <br />                                     neovascularization; physiological; embryonic stem cells; zebrafish; vasculature; signal <br />                                     transduction; IGF-2 <br />  <br />                                               Promotion neovasculature holds potential ameliorating coronary artery disease, <br />                                               leading cause morbidity mortality United States.1                                               focus inhibiting angiogenesis tumors, therapeutic angiogenesis emerging                                               exciting frontier cardiovascular medicine, recently articulated Ferrara                                               Kerbel.2  physiological revascularization essential embryogenesis tissue <br />                                               regeneration, occurs wound healing, ischemia,                                               tissue transplantation. <br />  <br />                                               formation neovasculature proceeds 2 distinct processes: vasculogenesis,                                               development primordial vasculature novo, angiogenesis, development NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               vasculature existing network.3 prevalent dogma neovasculature                                               adult established primarily process angiogenesis;  recent studies <br />                                               demonstrated endothelial progenitor cells promote neovascularization,4 <br />                                               presents paradigm vasculogenesis contributes therapeutic <br />                                               neovascularization adult. example, Transplantation Progenitor Cells                                               Regeneration Enhancement Acute Myocardial Infarction (TOPCARE-AMI) trial <br />                                               indicated circulating endothelial progenitor cells improve left ventricular ejection <br />                                               fraction patients myocardial infarction improving neovascularization.5 Recent <br />                                               studies demonstrated embryonic stem cells (ES cells) differentiate                                               functional endothelial cells (ES-ECs) vasculogenesis process.6,7 <br />                                               Bioluminescence imaging showed longitudinal survival transplanted ES-ECs,                                               echocardiography demonstrated functional improvement arose increased <br />                                               neovascularization.8 harnessing vasculogenesis potential revolutionize <br />                                               regenerative medicine contingent means regulate cellular differentiation. <br />  <br />                                               molecular mechanisms underlying vasculogenesis increasingly NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               elucidated, limited knowledge exists role cellular glyco-microenvironment                                               process.  angiogenic factors fibroblast growth factor-2 vascular <br />                                               endothelial growth factor shown bind heparan sulfate glycosaminoglycans <br />                                               (HSGAGs), key component glyco-microenvironment.9,10 Similarly, recent <br />                                               study, decreased N-sulfation HSGAG chains reduce platelet-derived growth <br />                                               factor-BB&#226;&#8364;&#8220;induced pericyte recruitment vascular development.11 present <br />                                               study, focused elucidating cross talk HSGAGs-glycome                                               transcriptome regulating vasculo-genesis, specifically differentiation ES cells                                               endothelium. HSGAGS linear N- O-sulfated biopolymers disaccharide units <br />                                               covalently linked glycosylphosphatidylinositol-anchored secreted proteins.                                               posttranslationally sulfated Golgi apparatus various glycosynthetic enzymes,  <br />  <br />  <br />                                                     Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                          Page 3 <br />  <br />  <br />                                               N-deacetylase/N-sulfotransferases (NDSTs) rate-limiting. demonstrate                                               expression glycosynthetic enzyme NDST1 sulfation HSGAGs <br />                                               increase vasculogenesis. Furthermore, pharmacological modulation sulfation <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               pattern knockdown NDST1 blocked vasculogenesis, rescued addition <br />                                               exogenous HSGAGs. confirmed findings vivo larval zebrafish,                                               downregulation NDST1 resulted impaired vascular development. Finally, identified <br />                                               downstream pathways mediate regulation vasculogenesis                                               HSGAGs. present study reveals exciting potential harnessing defined cellular <br />                                               glyco-microenvironments directed differentiation precursor cells adult tissue                                               vitro vivo. <br />  <br />  <br />                               Methods <br />                               Cell Culture <br />                                               Murine ES cells (129 substrain), obtained ATCC (Manassas, Va), differentiated <br />                                               leukemia inhibitory factor&#226;&#8364;&#8220;negative media seeding cells density 1600 cells/cm2 <br />                                               ultralow attachment conditions promote embryoid body formation. specific <br />                                               days, equal number cells taken dish subjected real-time <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               polymerase chain reaction (RT-PCR), Western blotting, immunohistochemistry                                               monitor expression endothelial cell markers. <br />  <br />                               Enzymatic <span id='am-1' about='obo:IMR_0000947' typeof='owl:Thing obo:IMR_0000001'><span id='am-2' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-3' property="oboInOwl:id" content="IMR:0000947" datatype="xsd:string"></span><span id='am-4' property="rdfs:label" content="chemical" datatype="xsd:string"></span>Chemical</span> Modification Glycocalyx <br />                                               ES cell-surface HSGAGs modified treatment 10 mU/mL heparinase  <br />                                               heparinase III, sodium chlorate. end experiments, cells collected, <br />                                               washed PBS, analyzed endothelial differentiation RT-PCR, immunoblotting, <br />                                               immunohistochemistry. HSGAG modification characterized capillary <br />                                               electrophoresis. <br />  <br />                               Isolation Compositional Analysis ES Cell-Surface HSGAGs <br />                                               Cells trypsinized 30 minutes 37&#194;&#176;C harvest cell-surface HSGAGs. Cells                                               counted normalize cell number subsequent capillary electrophoresis analysis. <br />                                               HSGAGs purified ultrafree DEAE column. Eluted fragments                                               concentrated Centricon filters (molecular weight cutoff 3 kDa; Millipore Corp, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               Billerica, Mass), freeze-dried overnight, digested 30&#194;&#176;C incubation 3 mIU <br />                                               heparinase  II, III. Digested glycosaminoglycan fragments analyzed                                               Agilent 3-dimensional capillary electrophoresis 72-cm extended light path <br />                                               capillary 75-&#206;&#188;m inner diameter (Agilent Technologies, Santa Clara, Calif). Negative <br />                                               polarity separation monitored 235 nm 50 mmol/L Tris, 10 mmol/L dextran sulfate <br />                                               buffer, pH 2.5. Peaks assigned comparison standards. <br />  <br />                               Short Hairpin RNA Lentivirus Infection <br />                                               selectively knock NDST1 forkhead box O3a (FOXO3A) ES cells,                                               infected cells using short hairpin RNAs (shRNAs) complementary NDST1, FOXO3A,                                               green fluorescent protein (GFP; gift Nir Hacohen, Center Immunology <span id='am-37' about='obo:IMR_0200083' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-38' property="oboInOwl:hasDbXref" content="KEGG:C00020" datatype="xsd:string"></span><span id='am-39' property="rdfs:label" content="AMP" datatype="xsd:string"></span><span id='am-40' property="oboInOwl:id" content="IMR:0200083" datatype="xsd:string"></span><span id='am-41' property="oboInOwl:hasExactSynonym" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-42' property="rdfs:label" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-43' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>amp</span>; <br />                                               Inflammatory Diseases, Massachusetts General Hospital, Boston, Mass). shRNA  <br />  <br />                                                    Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                            Page 4 <br />  <br />  <br />                                               inserted replication-deficient lentiviruses possess puromycin-resistant gene,                                               allows selection infected cells. Briefly, 24-hour-old embryoid bodies infected <br />                                               viruses 1 5 multiplicities infection presence polybrene transfection <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               reagent overnight. Fresh medium replenished 3 days. RNA harvested                                               specific time points infection subjected RT-PCR, described online                                               Data Supplement. <br />  <br />                               Zebrafish Studies <br />                                               Zebrafish [T&#195;&#188;bingenAB tg(Fli:eGFP)] embryos maintained standard E3 solution <br />                                               buffered HEPES 2 mmol/L. splice donor morpholino used inhibit                                               expression zebrafish NDST1. morpholino sequence based 8 overlapping <br />                                               3&#226;&#8364;&#178;-exons 3 predicted open reading frames, &gt;50% identity human NDST1                                               zebrafish genome assembly (Zv6 Sanger Institute Ensemble, Cambridge, United <br />                                               Kingdom; GenBank accession numbers XP_699032, XP_695253, XP_691043).                                               exon-3 splice donor morpholino predicted lead splicing exon 2 exon 4. <br />                                               Scrambled morpholinos used control. Increasing concentrations morpholinos <br />                                               injected 2-cell-stage embryos constant volume 4.6 nL Nanoject II <br />                                               (Drummond Scientific, Broomall, Pa). test patency vessels, 4.6 nL 10% <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               tetramethylrhodamine-labeled 40-kDa dextran (Molecular Probes, Carlsbad, Calif)                                               injected cardiac venous sinus. Bright-field fluorescence images embryos <br />                                               captured Nikon SMZ1500 stereomicroscope SPOT Flex camera <br />                                               (Diagnostic Instruments,  Sterling Heights, Mich). Image sequences obtained                                               setup exported movies match live flow patterns. procedures                                               approved Harvard University&apos;s Institutional Animal Care Use Committee. <br />  <br />                               Affymetrix Oligonucleotide Gene Arrays <br />                                               Embryos injected NDST1 morpholino wild-type siblings harvested                                               6- 20-somite developmental stages 24 hours fertilization (hpf). Total RNA <br />                                               extracted TRIzol reagent (Invitrogen, Carlsbad, Calif) purified Qiagen <br />                                               RNeasy columns (Qiagen, Valencia, Calif). Hybridization Affymetrix zebrafish genome <br />                                               arrays data acquisition performed Harvard Medical School Partners <br />                                               Healthcare Center Genetics Genomics. Quality control GeneChip <br />                                               Operating Software (GCOS; Affymetrix, Santa Clara, Calif) DNA-Chip Analyzer <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               (dChip).11a Acquired probe-level data normalized robust multichip average <br />                                               method, mean log 2 expression intensities triplicate experiments used                                               subsequent differential analysis. Local pooled error ANOVA differential expression <br />                                               testing performed S-Plus (Tibco Software, Palo Alto, Calif), P&lt;0.05                                               Bonferroni Benjamini-Hochberg corrections applied define significant genes                                               limit false-positive results, respectively. Regulated transcripts investigated use <br />                                               modified t test, R version Cyber-T algorithm. Gene pathways based                                               transcripts regulated robust multichip average method MAS5 data                                               3 time points Cyber-T fold-change criteria described defined                                               Cell Illustrator software Ingenuity Pathways Analysis (Ingenuity Systems,  <br />                                               Redwood City, Calif). Independent component analysis performed MATLAB <br />                                               software  MathWorks, Natick, Mass; online Data Supplement). Affymetrix <br />  <br />  <br />                                                     Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                            Page 5 <br />  <br />  <br />                                               probe sets annotated basis gene symbols available Affymetrix <br />                                               Netaffix World Wide Web site, Entrez Gene, Unigene, GenBank, Boston Trans-NIH <br />                                               Zebrafish Genome Initiative. Undefined transcripts identified Affymetrix probe IDs. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               subset differential transcript abundance confirmed RT-PCR. <br />  <br />                               Statistical Analysis <br />                                               results expressed mean&#194;&#177;SEM triplicate samples. Statistical <br />                                               comparisons obtained 1-way ANOVA followed Newman-Keuls post hoc test. <br />                                               Tests performed PRISM software (GraphPad Software, San Diego, Calif). <br />                                               Statistical comparisons 2 groups obtained Student t test. P&lt;0.05                                               considered significant. <br />  <br />  <br />                               Results <br />                               ES Cells Differentiate Endothelial Cells <br />                                               present study, selected characterized embryonic stem cell&#226;&#8364;&#8220;embryoid body <br />                                               (ESC-EB), closely mimics vivo maturation process, vitro model                                               study vasculogenesis. grown ultralow adherent conditions absence NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               leukemia inhibitory factor, ES cells start forming solid morula-like structures 2 days, <br />                                               progressively increase size finally cavitated (Figure 1B). shown                                               Figure 1A, expression levels endothelial cell markers VE-cadherin, VEGFR2 <br />                                               (vascular endothelial growth factor receptor-2), von Willebrand factor, Tie-2,                                               angiopoietin-2 increased, expression stem cell marker Oct 4 decreased <br />                                               progressively 10-day period, consistent differentiation vascular <br />                                               endothelial cells. Confocal imaging immunolabeling ESCEBs von <br />                                               Willebrand factor revealed negligible signal day 3 progressively increased time <br />                                               (Figure 1B). findings consistent previous reports12 increase                                               endothelial cell markers observed day 3 differentiation. Hemangioblast <br />                                               precursors established time point, coincides onset                                               vasculogenesis mouse embryo.13 <br />  <br />                               HSGAG Synthesis Upregulated ES Cell Differentiation <br />                                               Differentiation ES cells endothelial cells paralleled increase NDST1 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               transcripts protein, key regulator sulfation modification nascent <br />                                               HSGAG chain (Figure 1C 1D).14 investigate functional implication NDST1 <br />                                               expression, analyzed compositional changes cell-surface HSGAG ESC-EB <br />                                               differentiation using reverse-polarity capillary electrophoresis. Interestingly,                                               increase higher-order sulfated HSGAGs fragments ESC-EB differentiation <br />                                               (Figure 1E), indicates involvement glycocalyx vasculogenic process. <br />  <br />                               HSGAGs Modulate Differentiation ES Cells Endothelial Cells <br />                                               HSGAGs biopolymers disaccharide units uronic acid glucosamine                                               sulfated 3 residues (Figure 2A). Treatment sodium chlorate indirectly blocks                                               sulfation HSGAG competitively inhibiting formation 3&#226;&#8364;&#178;-phosphoadenosine-5&#226;&#8364;&#178;- <br />                                               phosphosulfate, high-energy sulfate donor cellular sulfation reactions.15 shown  <br />  <br />                                                     Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                             Page 6 <br />  <br />  <br />                                               Figure 2B, capillary electrophoresis cell-surface HSGAGs demonstrates absence                                               sulfated disaccharide peaks 7 days treatment sodium chlorate compared                                               untreated control cells. inhibition paralleled concentration-dependent decrease <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               protein expression endothelial cell marker von Willebrand factor (Figure 2C). <br />                                               Interestingly, expression endothelial cell marker restored                                               addition exogenous heparin (Figure 2D), establishes causal link                                               HSGAGs endothelium formation novo. validated treatment                                               differentiating cells heparinase III, digest HSGAGs regions                                               high low sulfation, respectively,16 resulted significant downregulation                                               endothelial cell markers (Figure 2E 2H; online Data Supplement Figure .                                               confirm role HSGAGS ES differentiation endothelial cells, knocked <br />                                               HSGAG-modifying enzyme NDST1 ES cells using NDST1 shRNA. shown <br />                                               Figure 2I, resulted 80% knockdown NDST1, translated significant <br />                                               reduction endothelial markers Tie-2, von Willebrand factor, angiopoietin-2, <br />                                               directly implicating NDST1 differentiation ES cells endothelial lineage. <br />  <br />                               Suppression NDST1 Leads Aberrant Vasculature Formation Zebrafish Embryo <br />                                               validate present vitro results vivo  adopted strategy NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               genetically manipulated HSGAG synthesis zebrafish embryos. BLAST (Basic Local <br />                                               Alignment Search Tool) analysis revealed zebrafish ortholog NDST1 chromosome <br />                                               21 (Figure 3I). Given variety predicted ATG initiation sites locus, splice donor <br />                                               morpholino designed exon shared 3&#226;&#8364;&#178;-end exons common 3 <br />                                               predicted transcripts. confirm effectiveness morpholino, designed specific <br />                                               primers RT-PCR RNA prepared injected control 72-hpf embryos. <br />                                               Sequencing subcloned fragments confirmed altered splicing resulted                                               premature stop codon. confirm morpholino resulted attenuation                                               HSGAG sulfation, harvested cell-surface HSGAGs 24-hpf embryos                                               subjected compositional analysis using capillary electrophoresis. shown                                               Figure 3 (II), NDST1 knockdown resulted significant reduction sulfated <br />                                               disaccharides. <br />  <br />                                               seen Figure 3 (III), morpholino-induced knockdown NDST1 resulted                                               concentration-dependent aberrant formation dorsal aorta, caudal vein, intersegmental <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               vessels, contributed shortened, dysmorphic tails. higher <br />                                               concentrations morpholino resulted complete ablation blood flow                                               cloacae resulted dysmorphic tails, lower concentrations produced proximal <br />                                               confluence dorsal aorta posterior cardinal vein. lower concentrations <br />                                               induced vascular abnormalities, shortening tail observed, suggests                                               dysmorphic tail secondary result primary abnormal vascularization.                                               cases, stagnant blood cells space usually occupied caudal vein <br />                                               plexus moved synchronously heartbeat (Figure 3 [IIIB]; online Data <br />                                               Supplement Movie . findings consistent T&#195;&#188;bingenAB                                               tg(Fli:GFP) embryos. Decreased vascular blood flow zNDST1 embryos associated <br />                                               smaller vessel lumen, evident injection 40 kDa tetramethylrhodamine- <br />                                               labeled dextran. <br />  <br />  <br />                                                     Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                                Page 7 <br />  <br />  <br />                               Exogenous Sulfated HSGAGs Rescues Impaired Vascular Phenotype <br />                                               test exogenous sulfated HSGAGs induce recovery vascular phenotype, NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               treated NDST1 knockdown cells heparin, highly sulfated HSGAG analog. <br />                                               shown Figure 4, treatment heparin increased endothelium-specific transcripts. <br />                                               Furthermore, heparin induced partial recovery phenotype NDST1-knockdown <br />                                               zebrafish (Figure 4B). <br />  <br />                               Glycocalyx Modifications Modulate Transcriptome Signatures Developing Zebrafish <br />                               Embryo <br />                                               elucidate glycocalyx-mediated effects transcriptome regulators vasculogenesis,                                               performed global gene-expression analysis zNDST1 morphants wild-type siblings                                               6-somite, 20-somite, 24-hpf time points, correspond significant stages                                               zebrafish vessel development (migration angioblasts midline, major lateral vessel <br />                                               formation, intersegmental angiogenesis).17 local pooled error method used                                               identify differentially expressed transcripts zNDST1 mutants wild-type siblings <br />                                               3 developmental stages, revealed 218 significant transcripts (corrected P value <br />                                               &lt;0.05, fold-change &lt;0.75 &gt;1.25; online Data Supplement Table . Hierarchal <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               clustering Euclidean distance metric demonstrated distinct temporal expression <br />                                               patterns 50 transcripts (Figure 5A). Independent component analysis confirmed <br />                                               local pooled error analysis, 93% transcripts identified                                               differentially expressed local pooled error analysis 0.5%                                               transcripts contributed NDST1-associated ICA component 2 (Figure 5B).                                               Independent Component Analysis component 2 additionally identified 34 genes <br />                                               associated NDST knockdown (online Data Supplement Table V). ANOVA <br />                                               analysis MAS5-normalized data used define significant changes gene <br />                                               transcription comparison developmental stages (Benjamini-Hochberg corrected P <br />                                               value &lt;0.05; online Data Supplement Table II). Notably, greater number                                               significant transcripts 20-somite stage (619) 6-somite stage <br />                                               (67) 24 hpf (119), shown Figure 5C. Regulated genes significant cell <br />                                               signaling, transcription factors, cell proliferation/differentiation, protein stability, apoptosis, <br />                                               matrix interactions highlighted Figure 5D. Finally, data log base 2 <br />                                               transformed, normalized MAS5 robust multichip average methods,                                               analyzed Cyber-T (P&#226;&#8240;&#164;0.05, mean fold-change &#226;&#8240;&#164;2 NDST1 morphant NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               wild type; online Data Supplement Tables III IV). ANOVA method, <br />                                               analysis, 20-somite stage differentially regulated transcripts, <br />                                               overlapping transcripts existed different stages (Figure 6A). <br />                                               Pathway analysis based regulated transcripts developmental stage revealed <br />                                               interconnected networks regulate apoptosis, differentiation, cell matrix, cell-cell <br />                                               interaction (Figure 6B 6D). <br />  <br />  <br />                               Discussion <br />                                               present study, focused roles glycosaminoglycan component                                               cell-surface glycome modulating vasculogenesis. step, recapitulated <br />                                               vasculogen esis ESC-EBs. primary vascular plexus formed embryonic body <br />  <br />  <br />                                                     Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                           Page 8 <br />  <br />  <br />                                               undergoes remodeling day 6 7 onward sprouting angiogenesis.12,13 Interestingly, <br />                                               comparison compositional analysis cell-surface HSGAGs day 3 day <br />                                               7 ESC-EB revealed distinct profiles led increase highly sulfated disaccharide <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               residues differentiation. sulfate residues introduced nascent polymer <br />                                               series sequential enzyme-induced modifications. bifunctional activity                                               NDST family appears key regulator process,                                               modifications,  C5 epimerization 2O, 3O, 6O sulfations, predominate <br />                                               N-sulfated regions. Interestingly, mRNA transcripts total NDST1 <br />                                               protein levels upregulated vasculogenesis, explain increased <br />                                               sulfation HSGAG polymer. 4 isoforms NDST distinct tissue <br />                                               distribution,18 NDST1 NDST2 isoforms expressed vasculature.19 <br />                                               separate study, Johnson et al20 demonstrated similar upregulation NDST4 <br />                                               isoform ESC-EBs directed differentiate neural lineage.                                               observations implicate HSGAG synthetic enzymes differentiation process,                                               indicates postpolymerization modifications introduced nascent chains                                               play critical roles differentiation process specific lineages. <br />  <br />                                               test hypothesis  used morpholino-based approach knock NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               expression NDST1 developing zebrafish embryo model, emerged                                               excellent study vasculogenesis transparent embryo allows real- <br />                                               time functional monitoring evolving vasculature.21 previous study, genetic <br />                                               perturbation HSGAG synthesis resulted early developmental defects, including <br />                                               failure differentiate mesodermal precursors endothelium,22,23 prevented <br />                                               characterization vasculogenesis studies. limitation overcome <br />                                               zebrafish model, real-time monitoring embryo revealed                                               oligonucleotide-induced knockdown NDST1 resulted reduction HSGAG sulfation, <br />                                               led abnormal vasculature stunting tail, consistent hypothesis <br />                                               glycocalyx implicated vasculogenesis. Additionally, shRNA knockdown                                               NDST1 significantly suppressed expression endothelial markers embryoid <br />                                               bodies. supported fact treatment differentiating embryoid <br />                                               bodies heparinase III resulted inhibition vasculogenesis. Similarly, sodium <br />                                               chlorate, prevents sulfation nascent polymer, blocked vasculogenesis.                                               validated partial recovery endothelial phenotype NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               embryoid body zNDST1-knockdown zebrafish addition exogenous <br />                                               heparin, highly sulfated HSGAG analog. results implicate causal link <br />                                               glycome composition endothelium formation. <br />  <br />                                               previous study, demonstrated cellular pheno-type coregulated                                               cross talk glycome transcriptome.24 Interestingly, Jakobsson et al25 <br />                                               demonstrated HSGAGs expressed perivascular smooth muscle cells support <br />                                               development capillary structures NDST1/2-/- embryonic stem cells,                                               suggests just endothelial cell-surface HSGAGs glycocalyx                                               surrounding cellular architecture exert &#226;&#8364;&#339;bystander effect&#226;&#8364;? modulating <br />                                               vasculogenesis. decided globally knock NDST1 study effect <br />  <br />  <br />  <br />  <br />                                                     Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                             Page 9 <br />  <br />  <br />                                               transcriptome, developed mechanistic models based differentially <br />                                               regulated transcripts implicated neovascularization. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               surprisingly, large number genes differentially regulated                                               involved signal transduction morphogenesis transcription factors                                                online Data Supplement details). example, spleen tyrosine kinase (SYK)                                               upregulated NDST1knockdown embryos. SYK candidate tumor-suppressor gene                                               implicated suppression cyclin D1.26 suppresses cell motility inhibiting <br />                                               <span id='am-5' about='obo:IMR_0001650' typeof='owl:Thing obo:IMR_0001356 obo:IMR_0000947 obo:IMR_0001382 obo:IMR_0000001 obo:IMR_0001384 obo:IMR_0001362'><span id='am-6' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-7' property="oboInOwl:id" content="IMR:0001650" datatype="xsd:string"></span><span id='am-8' property="rdfs:label" content="phosphoinositide" datatype="xsd:string"></span><span id='am-9' property="rdfs:label" content="inositol phospholipid" datatype="xsd:string"></span><span id='am-10' property="oboInOwl:hasExactSynonym" content="phosphoinositide" datatype="xsd:string"></span>phosphoinositide</span>-3 kinase activity urokinase-type plasminogen activator secretion, <br />                                               critical neovascularization.27 Interestingly, <span id='am-11' about='obo:IMR_0001651' typeof='owl:Thing obo:IMR_0001650 obo:IMR_0001356 obo:IMR_0000947 obo:IMR_0001382 obo:IMR_0000001 obo:IMR_0001384 obo:IMR_0001362'><span id='am-12' property="oboInOwl:hasExactSynonym" content="phosphoinositide" datatype="xsd:string"></span><span id='am-13' property="rdfs:label" content="phosphoinositide" datatype="xsd:string"></span><span id='am-14' property="rdfs:label" content="MPI" datatype="xsd:string"></span><span id='am-15' property="rdfs:label" content="phosphatidylinositol" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:hasDbXref" content="KEGG:C00626" datatype="xsd:string"></span><span id='am-17' property="oboInOwl:id" content="IMR:0001651" datatype="xsd:string"></span><span id='am-18' property="oboInOwl:hasExactSynonym" content="MPI" datatype="xsd:string"></span><span id='am-19' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-20' property="rdfs:label" content="inositol phosphoglyceride" datatype="xsd:string"></span><span id='am-21' property="oboInOwl:hasExactSynonym" content="inositol phosphoglyceride" datatype="xsd:string"></span><span id='am-22' property="rdfs:label" content="monophosphoinositide" datatype="xsd:string"></span><span id='am-23' property="oboInOwl:hasExactSynonym" content="monophosphoinositide" datatype="xsd:string"></span>phosphoinositide</span>-3 kinase                                               negatively regulates FOXO, described  observed downregulation                                               Wnt receptor, Frizzled, NDST1-knockdown embryos, morphogen, <br />                                               sonic hedgehog (Shh). Previous studies zebrafish revealed vascular defects                                               Shh-mutant embryos.28 <br />  <br />                                               Interestingly, despite implication HSGAGs involved vascular endothelial <br />                                               growth factor, fibroblast growth factor, platelet-derived growth factor signaling                                               angiogenesis,8&#226;&#8364;&#8220;10 signals directly modulated NDST1 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               knockdown embryos. Instead, transcription factor FOXO5 (zebrafish ortholog FOXO3A) <br />                                               insulin-like growth factor-2 (IGF2) consistently upregulated 3 <br />                                               time points. elegant study, Potente et al29 demonstrated vivo FOXO3A <br />                                               deficiency increased vessel formation maturation. dissected pathway                                               embryoid body model. shown Figure 7, observed FOXO3A levels <br />                                               decreased cells differentiated endothelial cells. Interestingly, shRNA-mediated <br />                                               knockdown NDST1 increased FOXO3A transcript protein expression,                                               suggests FOXO3A downstream signal glycome modification. Furthermore, <br />                                               shRNA-mediated knockdown FOXO3A embryoid bodies resulted decreased <br />                                               IGF2 transcripts, suggests IGF2 modulated FOXO.                                                evidence bidirec tional signaling IGFs FOXO.30 recent study                                               demonstrated self-renewal pluripotent properties ES cells require IGF <br />                                               signaling.31 contrast, study demonstrated IGF2 implicated homing                                               endothelial progenitor cells.32 indicates regulation IGF activity differentiation <br />                                               progenitor cells endothelial cells, warrants studies. additional <br />                                               pathways coordinating glycome-transcriptome cross talk vasculogenesis, NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               present results clearly implicate FOXOIGF signaling axis process. <br />  <br />                                               conclusion, clearly demonstrate involvement HSGAGs, key components                                               cell-surface glycome, vasculo-genesis. Furthermore, elucidated                                               critical downstream pathways implicated mediating glycome regulation                                               vasculogenesis. study reveals exciting potential harnessing defined cellular <br />                                               glycomicroenvironments directed differentiation precursor cells therapeutic <br />                                               neovascularization. <br />  <br />                                                <br />  <br />  <br />  <br />  <br />                                                     Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                                       Page 10 <br />  <br />  <br />                               Supplementary Material <br />                                               Refer Web version PubMed Central supplementary material. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Acknowledgments <br />                                               Sources Funding <br />  <br />                                               Dr Sengupta supported Scientist Development Grant American Heart Association                                               Department Defense Breast Cancer Research Program Era Hope Scholar Award. Dr Harfouche supported <br />                                               Canadian Institutes Health Research postdoctoral fellowship. <br />  <br />  <br />                               References <br />                                               1. Heart disease stroke statistics&#226;&#8364;&#8221;2007 update: report American Heart Association <br />                                                  Heart Statistics Committee Stroke Statistics Subcommittee. Circulation. 2007; 115:e69&#226;&#8364;&#8220;e171. <br />                                                  [PubMed: 17194875] <br />                                               2. Ferrara N, Kerbel RS. Angiogenesis therapeutic target. Nature. 2005; 438:967&#226;&#8364;&#8220;974. [PubMed: <br />                                                  16355214] <br />                                               3. Risau W. Mechanisms angiogenesis. Nature. 1997; 386:671&#226;&#8364;&#8220;674. [PubMed: 9109485] <br />                                               4. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, <br />                                                  Itescu S. Neovascularization ischemic myocardium human bone-marrow-derived angioblasts <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                  prevents cardiomyocyte apoptosis, reduces remodeling improves cardiac function. Nat Med. <br />                                                  2001; 7:430&#226;&#8364;&#8220;436. [PubMed: 11283669] <br />                                               5. Sch&#195;&#164;chinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C, Abolmaali ND, Vogl TJ, <br />                                                  Hofmann WK, Martin H, Dimmeler S, Zeiher  Transplantation progenitor cells                                                  regeneration enhancement acute myocardial infarction: final year results TOPCARE- <br />                                                  AMI Trial. J Coll Cardiol. 2004; 44:1690&#226;&#8364;&#8220;1699. [PubMed: 15489105] <br />                                               6. Yamashita J, Itoh H, Hirashima M, Ogawa M, Nishikawa S, Yurugi T, Naito M, Nakao K, <br />                                                  Nishikawa S. Flk1-positive cells derived embryonic stem cells serve vascular progenitors. <br />                                                  Nature. 2000; 408:92&#226;&#8364;&#8220;96. [PubMed: 11081514] <br />                                               7. Levenberg S, Golub JS, Amit M, Itskovitz-Eldor J, Langer R. Endothelial cells derived human <br />                                                  embryonic stem cells. Proc Natl Acad Sci U S  2002; 99:4391&#226;&#8364;&#8220;4396. [PubMed: 11917100] <br />                                               8. Li  Wu JC, Sheikh AY, Kraft D, Cao F, Xie X, Patel M, Gambhir SS, Robbins RC, Cooke JP, Wu <br />                                                  JC. Differentiation, survival, function embryonic stem cell derived endothelial cells                                                  ischemic heart disease. Circulation. 2007; 116(suppl) 46 54. <br />                                               9. Lundin L, Larsson H, Kreuger J, Kanda S, Lindahl U, Salmivirta M, Claesson-Welsh L. Selectively <br />                                                  desulfated heparin inhibits fibroblast growth factor-induced mitogenicity angiogenesis. J Biol <br />                                                  Chem. 2000; 275:24653&#226;&#8364;&#8220;24660. [PubMed: 10816596] <br />                                               10. Gitay-Goren H, Soker S, Vlodavsky  Neufeld G. binding vascular endothelial growth <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                    factor receptors dependent cell surface-associated heparin-like molecules. J Biol Chem. <br />                                                    1992; 267:6093&#226;&#8364;&#8220;6098. [PubMed: 1556117] <br />                                               11. Abramsson  Kurup S, Busse M, Yamada S, Lindblom P, Schallmeiner E, Stenzel D, Sauvaget D, <br />                                                    Ledin J, Ringvall M, Landegren U, Kjell&#195;&#169;n L, Bondjers G, Li JP, Lindahl U, Spillmann D, <br />                                                    Betsholtz C, Gerhardt H. Defective N-sulfation heparan sulfate proteoglycans limits PDGF-BB <br />                                                    binding pericyte recruitment vascular development. Genes Dev. 2007; 21:316&#226;&#8364;&#8220;331. <br />                                                    [PubMed: 17289920] <br />                                               11a. Li C, Wong H. Model-based analysis oligonucleotide arrays: expression index computation                                                      outlier detection. Proc Natl Acad Sci. 2001; 98:31&#226;&#8364;&#8220;36. [PubMed: 11134512] <br />                                               12. Evans AL, Bryant J, Skepper J, Smith SK, Print CG, Charnock-Jones DS. Vascular development                                                    embryoid bodies: quantification transgenic intervention antiangiogenic treatment. <br />                                                    Angiogenesis. 2007; 10:217&#226;&#8364;&#8220;226. [PubMed: 17577673] <br />                                               13. Nakagami H, Nakagawa N, Takeya Y, Kashiwagi K, Ishida C, Hayashi S, Aoki M, Matsumoto K, <br />                                                    Nakamura T, Ogihara T, Morishita R. Model vasculogenesis embryonic stem cells  <br />  <br />  <br />                                                     Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                                  Page 11 <br />  <br />  <br />                                                   vascular research regenerative medicine. Hypertension. 2006; 48:112&#226;&#8364;&#8220;119. [PubMed: <br />                                                   16754788] <br />                                               14. Grobe K, Ledin J, Ringvall M, Holmborn K, Forsberg E, Esko JD, Kjell&#195;&#169;n L. Heparan sulfate NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   development: differential roles N-acetylglucosamine N-deacetylase/N-sulfotransferase <br />                                                   isozymes. Biochim Biophys Acta. 2002; 1573:209&#226;&#8364;&#8220;215. [PubMed: 12417402] <br />                                               15. Delehedde M, Seve M, Sergeant N, Wartelle  Lyon M, Rudland PS, Fernig DG. Fibroblast <br />                                                   growth factor-2 stimulation p42/44MAPK phosphorylation IkappaB degradation                                                   regulated heparan sulfate/heparin rat mammary fibroblasts. J Biol Chem. 2000; 275:33905&#226;&#8364;&#8220; <br />                                                   33910. [PubMed: 10944532] <br />                                               16. Ernst S, Langer R, Cooney CL, Sasisekharan R. Enzymatic degradation glycosaminoglycans. <br />                                                   Crit Rev Biochem Mol Biol. 1995; 30:387&#226;&#8364;&#8220;444. [PubMed: 8575190] <br />                                               17. Jin SW, Beis D, Mitchell T, Chen JN, Stainier DY. Cellular molecular analyses vascular <br />                                                   tube lumen formation zebrafish. Development. 2005; 132:5199&#226;&#8364;&#8220;5209. [PubMed: 16251212] <br />                                               18. Iozzo RV. Basement membrane proteoglycans: cellar ceiling. Nat Rev Mol Cell Biol. <br />                                                   2005; 6:646&#226;&#8364;&#8220;656. [PubMed: 16064139] <br />                                               19. Esko JD, Selleck SB. Order chaos: assembly ligand binding sites heparan sulfate. Annu <br />                                                   Rev Biochem. 2002; 71:435&#226;&#8364;&#8220;471. [PubMed: 12045103] <br />                                               20. Johnson CE, Crawford  Stavridis M, Dam G, Wat AL, Rushton G, Ward CM, Wilson V, <br />                                                   van Kuppevelt TH, Esko JD, Smith  Gallagher JT, Merry CL. Essential alterations heparan <br />                                                   sulfate differentiation embryonic stem cells Sox1-enhanced green fluorescent <br />                                                   protein-expressing neural progenitor cells. Stem Cells. 2007; 25:1913&#226;&#8364;&#8220;1923. [PubMed: 17464092] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               21. Kidd KR, Weinstein BM. Fishing novel angiogenic therapies. Br J Pharmacol. 2003; 140:585&#226;&#8364;&#8220; <br />                                                   594. [PubMed: 14534143] <br />                                               22. Lin X, Wei G, Shi  Dryer L, Esko JD, Wells  Matzuk MM. Disruption gastrulation                                                   heparin sulfate biosynthesis EXT1-deficient mice. Dev Biol. 2000; 224:299&#226;&#8364;&#8220;311. [PubMed: <br />                                                   10926768] <br />                                               23. Stickens D, Zak BM, Rougier N, Esko JD, Werb  Mice deficient Ext2 lack heparan sulfate                                                   develop exotoses. Development. 2005; 132:5055&#226;&#8364;&#8220;5068. [PubMed: 16236767] <br />                                               24. Johnson NA, Sengupta S, Saidi SA, Lessan K, Charnock-Jones SD, Scott L, Stephens R, Freeman <br />                                                   TC, Tom BD, Harris M, Denyer G, Sundaram M, Sasisekharan R, Smith SK, Print CG. <br />                                                   Endothelial cells preparing die apoptosis initiate program transcriptome glycome <br />                                                   regulation. FASEB J. 2004; 18:188&#226;&#8364;&#8220;190. [PubMed: 14630703] <br />                                               25. Jakobsson Kreuger J, Holmborn K, Lundin L, Eriksson  Kjell&#195;&#169;n L, Claesson-Welsh L. Heparan <br />                                                   sulfate trans potentiates VEGFR-mediated angiogenesis. Dev Cell. 2006; 10:625&#226;&#8364;&#8220;634. <br />                                                   [PubMed: 16678777] <br />                                               26. Wang L, Devarajan E, J, Reddy SP, Dai JL. Transcription repressor activity spleen tyrosine <br />                                                   kinase mediates breast tumor suppression. Cancer Res. 2005; 65:10289&#226;&#8364;&#8220;10297. [PubMed: <br />                                                   16288017] <br />                                               27. Mahabeleshwar GH, Kundu GC. SYK, protein tyrosine kinase, suppresses cell motility                                                   nuclear factor kappa B-mediated secretion urokinase type plasminogen activator inhibiting <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   <span id='am-24' about='obo:IMR_0001651' typeof='owl:Thing obo:IMR_0001650 obo:IMR_0001356 obo:IMR_0000947 obo:IMR_0001382 obo:IMR_0000001 obo:IMR_0001384 obo:IMR_0001362'><span id='am-25' property="oboInOwl:hasExactSynonym" content="MPI" datatype="xsd:string"></span><span id='am-26' property="rdfs:label" content="MPI" datatype="xsd:string"></span><span id='am-27' property="oboInOwl:hasDbXref" content="KEGG:C00626" datatype="xsd:string"></span><span id='am-28' property="rdfs:label" content="monophosphoinositide" datatype="xsd:string"></span><span id='am-29' property="oboInOwl:hasExactSynonym" content="monophosphoinositide" datatype="xsd:string"></span><span id='am-30' property="rdfs:label" content="inositol phosphoglyceride" datatype="xsd:string"></span><span id='am-31' property="oboInOwl:id" content="IMR:0001651" datatype="xsd:string"></span><span id='am-32' property="rdfs:label" content="phosphoinositide" datatype="xsd:string"></span><span id='am-33' property="oboInOwl:hasExactSynonym" content="phosphoinositide" datatype="xsd:string"></span><span id='am-34' property="oboInOwl:hasExactSynonym" content="inositol phosphoglyceride" datatype="xsd:string"></span><span id='am-35' property="rdfs:label" content="phosphatidylinositol" datatype="xsd:string"></span><span id='am-36' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>phosphatidylinositol</span> 3&#226;&#8364;&#178;-kinase activity breast cancer cells. J Biol Chem. 2003; 278:6209&#226;&#8364;&#8220; <br />                                                   6221. [PubMed: 12477728] <br />                                               28. Chen JN, Haffter P, Odenthal J, Vogelsang E, Brand M, van Eeden FJ, Furutani-Seiki M, Granato <br />                                                   M, Hammerschmidt M, Heisenberg CP, Jiang YJ, Kane DA, Kelsh RN, Mullins MC, N&#195;&#188;sslein- <br />                                                   Volhard C. Mutations affecting cardiovascular internal organs zebrafish. <br />                                                   Development. 1996; 123:293&#226;&#8364;&#8220;302. [PubMed: 9007249] <br />                                               29. Potente M, Urbich C, Sasaki K, Hofmann WK, Heeschen C, Aicher  Kollipara R, DePinho RA, <br />                                                   Zeiher  Dimmeler S. Involvement Foxo transcription factors angiogenesis postnatal <br />                                                   neovascularization. J Clin Invest. 2005; 115:2382&#226;&#8364;&#8220;2392. [PubMed: 16100571] <br />                                               30. Liu TJ, Lai HC, Ting CT, Wang PH. Bidirectional regulation upstream IGF insulin receptor <br />                                                   signaling downstream FOXO1 cardiomyocytes. J Endocrinol. 2007; 192:149&#226;&#8364;&#8220;158. <br />                                                   [PubMed: 17210752] <br />                                               31. Bendall SC, Stewart MH, Menendez P, George D, Vijayaragavan K, Werbowetski-Ogilvie T, <br />                                                   Ramos-Mejia V, Rouleau  Yang J, Boss&#195;&#169; M, Lajoie G, Bhatia M. IGF FGF cooperatively <br />  <br />  <br />                                                     Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                             Page 12 <br />  <br />  <br />                                                   establish regulatory stem cell niche pluripotent human cells vitro. Nature. 2007; <br />                                                   448:1015&#226;&#8364;&#8220;1021. [PubMed: 17625568] <br />                                               32. Maeng Y, Choi H, Kwon J, Park YW, Choi KS, Min JK, Kim YH, Suh PG, Kang KS, Won MH, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Kim YM, Kwon YG. Endothelial progenitor cell homing: prominent role IGF2-IGF2R- <br />                                                   PLCbeta2 axis. Blood. 2009; 113:233&#226;&#8364;&#8220;243. [PubMed: 18832656] <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                     Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                          Page 13 <br />  <br />  <br />  <br />                                                                                 CLINICAL PERSPECTIVE <br />                                               Promotion neovasculature holds potential ameliorating coronary artery disease. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               TOPCARE-AMI (Transplantation Progenitor Cells Regeneration <br />                                               Enhancement Acute Myocardial Infarction) trial indicated circulating endothelial <br />                                               progenitor cells improve left ventricular ejection fraction patients                                               myocardial infarction. Recent studies demonstrated embryonic stem cells                                               differentiate functional endothelial cells vasculogenesis, results                                               functional improvement arises increased neovascularization. harnessing                                               vasculogenesis potential revolutionize regenerative medicine contingent <br />                                               means regulate cellular differentiation. present study, demonstrate                                               glyco-microenvironment stem cell, specifically sulfated heparan sulfate <br />                                               glycosaminoglycans, plays critical role facilitating vasculogenesis. confirmed <br />                                               findings vivo larval zebrafish, desulfation heparan sulfate <br />                                               glycosaminoglycans resulted impaired vascular development. phenotype                                               rescued exogenous sulfated heparan sulfate glycosaminoglycans. Finally,                                               identified downstream pathways mediate regulation                                               vasculogenesis heparan sulfate glycosaminoglycans, including novel FOXO3A/5- <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               IGF2 signaling pathway. study reveals exciting potential harnessing defined <br />                                               cellular glyco-microenvironments directed differentiation precursor cells                                               endothelial cells, leading neovascularization. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                     Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                        Page 14 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                                                              Figure 1. <br />                                Differentiation ES cells endothelium.  vi, Quantification endothelial cell transcripts (VE-cadherin, vascular <br />                            endothelial growth factor receptor 2 [VEGFR2], von Willebrand factor [vWF], Tie-2, angiopoietin-2 [Ang2]) stem cell <br />                              marker Oct 4 RT-PCR. B, Bright-field confocal images embryoid bodies stained vWF confirm differentiation <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                 endothelial lineage. Images captured LSM510 confocal microscope 488-nm wavelength                             excitation emission 516 nm. Inset  ii) represents isotype control immunohistochemistry primary antibody <br />                            control. PI indicates propidium iodide. C, RT-PCR analysis revealed expression NDST1 differentiation. D, Western <br />                             blot shows expression NDST1 protein time differentiating embryoid body. E, Compositional analysis HSGAGs <br />                             capillary electrophoresis heparinase digestion revealed negligible sulfated disaccharides day 3 compared day 7, <br />                                    vascular precursors established. data expressed grades intensity signal                              electropherogram. Tri-S indicates trisaccharide; Di-S, disaccharide; Mono-S, <span id='am-44' about='obo:IMR_0002125' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000001'><span id='am-45' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-46' property="oboInOwl:hasDbXref" content="CHEBI:35381" datatype="xsd:string"></span><span id='am-47' property="oboInOwl:hasDbXref" content="MeSH:D009005" datatype="xsd:string"></span><span id='am-48' property="oboInOwl:id" content="IMR:0002125" datatype="xsd:string"></span><span id='am-49' property="rdfs:label" content="monosaccharide" datatype="xsd:string"></span>monosaccharide</span>; Rn, normalized reporter. <br />                                                                      ***P&lt;0.001 compared day 3 control cells. <br />  <br />  <br />  <br />  <br />                                                   Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                          Page 15 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                                                               Figure 2. <br />                            Pharmacological modulation HSGAGs regulates vasculogenesis.  Typical disaccharide building block HSGAG polymer <br />                              comprises uronic acid glucosamine. sulfated residue X sulfated acetylated Y. B, Treatment ES <br />                            cells sodium chlorate (Sod. chlorate) inhibited sulfation nascent chain, seen capillary electrophoresis. Data                               expressed grades intensity signal electropherogram. ND indicates nondetectable; Tri-S, trisaccharide; Di-S, <br />                               disaccharide; Mono-S, monosaccharide. C, Fluorescence-activated cell sorter analysis expression von Willebrand <br />                              factor (vWF) sodium chlorate&#226;&#8364;&#8220;treated embryoid bodies showed concentration-dependent inhibition vasculogenesis (D) <br />                             reversed exogenous heparin. E&#226;&#8364;&#8220;H, Differentiation ES cells endothelial cells inhibited treatment <br />                                heparinase III sodium chlorate quantified monitoring level transcripts endothelial cell markers <br />                              (vascular endothelial growth factor receptor 2 [VEGFR2], angiopoietin 2 [Ang2], Tie-2, vWF) RT-PCR. **P&lt;0.05, <br />                              **P&lt;0.01, ***P&lt;0.001 compared control. #P&lt;0.01 vs day 3.  NDST1 gene knocked ESC-EBs 7 days <br />                                 NDST1 shRNA (gray bars), gene expression NDST1 endothelial markers (Tie-2, vWF, Ang2)                            quantified RT-PCR. GFP shRNA served internal control (black bars). *P&lt;0.05 compared GFP-shRNA. Veh indicates <br />                                                                  vehicle; Rn, normalized reporter; Hep., heparinase. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                    Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                     Page 16 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                                                              Figure 3. <br />                                Morpholino-induced knockdown NDST1 impairs vasculogenesis zebrafish embryo.  BLAST analysis revealed 3 <br />                            zebrafish orthologs zNDST1 chromosome 21 60% sequence identity mouse NDST (mNDST). B, morpholino <br />                            (GTGCATTTAACACTCACCATTCTTC) designed block splice donor site exon 3 (Ex3 Mo). WT indicates wild <br />                                 type. C, RT-PCR confirmed effectiveness morpholino dose-dependent manner. Sequencing subcloned <br />                             fragments confirmed altered splicing resulted premature STOP codon. II, Capillary electrophoresis HSGAG profile <br />                                wild-type NDST1 knockdown (NDST1-kd) zebrafish 24 hpf revealed absence sulfated disaccharides                            NDST1 knockdown compared wild type. Data expressed grades intensity signal electropherogram. <br />  <br />  <br />                                                   Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                     Page 17 <br />  <br />  <br />                            Tri-S indicates trisaccharide; Di-S, disaccharide; Mono-S, monosaccharide; ND, nondetectable. III  Morpholino-injected <br />                             tg(Fli1;GFP) fish displayed decreased intersegmental vessels dysmorphic tails dose-dependent manner. III-B, Bright- <br />                              field images T&#195;&#188;bingenAB 48-hpf WT fish   1.15-pmol morpholino&#226;&#8364;&#8220;injected fish. Blood cells accumulated NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             caudal vein plexus morpholino-injected embryos. III-C,  54-hpf tg(Fli:GFP) embryos injected low-dose zNDST1 <br />                            morpholino displayed weaker density tail intersegmental vessels.  40-kDa tetramethylrhodamine (TMR) injected                                                     WT knockdown fish revealed smaller lumens zNDST-injected embryos. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                  Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                      Page 18 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                                                             Figure 4. <br />                              Exogenous heparin rescues NDST1-knockdown (NDST1-kd) phenotype.  RT-PCR data showing transcript levels                             endothelial cell markers, Tie-2 VEGFR2 (vascular endothelial growth factor receptor 2), differentiating ES cells                             shRNA-induced NDST1 knockdown. Incubation heparin (20 &#206;&#188;g/mL) induced recovery transcript levels NDST1 <br />                            knockdown. Data mean&#194;&#177;SE (n=3). B, Injection heparin zNDST1 morpholino-treated zebrafish resulted partial <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             recovery tail phenotype, used reporter vascularization defects. Graph shows mean tail lengths &#194;&#177;SE 7 8 <br />                                                        fish treatment group. *P&lt;0.05, **P&lt;0.01, ***P&lt;0.001 vs controls. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                  Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                            Page 19 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                                                               Figure 5. <br />                             Temporal transcriptome analysis wild-type (WT) vs NDST1 knockdown zebrafish.  Heat map created 50 <br />                            significant transcripts according local pooled error testing S-Plus software. Differential expression trends clearly visible <br />                                  WT morphant zebrafish embryos 6-somite, 20-somite, 24-hpf developmental stages. Unidentified <br />                             transcripts denoted Affymetrix identification numbers. B, Hinton plot created independent component analysis <br />                                   robust multichip average (RMA) method&#226;&#8364;&#8220;normalized expression levels reveal gene signatures method                            independent parametric statistics. Columns represent chips; rows represent latent gene signatures. Colors sizes squares <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                represent direction (positive negative) degree component represented chip. Components <br />                                specific knockdown, developmental stage, individual biological replicates arrowed. Ninety percent                                 transcripts identified differentially expressed local pooled error analysis 0.5% transcripts                                 contributed independent component analysis component 2, separated WT NDST1 knockdown. C, ANOVA <br />                            analysis (P&lt;0.05) S-Plus revealed 67, 619, 119 regulated transcripts WT morphant RNA 6-somite, 20- <br />                               somite, 24 hpf stages, respectively. 34 transcripts overlapped developmental stages highlighted                            Venn diagram. Inset shows confirmation zebrafish FOXO5 IGF2 expression quantitative PCR. D, Cartoon classifying <br />                               transcripts modulated WT NDST1 implicated neovascularization. 6S indicates 6 somite; <br />                                                                           20S, 20 somite; Rn, normalized reporter. <br />  <br />  <br />  <br />  <br />                                                    Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                        Page 20 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                                                              Figure 6. <br />                              Pathways implicated glycocalyx regulation vasculogenesis.  time point, scatterplots compare mean transcript <br />                             abundance 3 wild-type replicates (x axis) 3 zNDST1 morphant replicates (y axis). transcripts                            P&#226;&#8240;&#165;0.01 fold-change &#226;&#8240;&#164;2 Cyber-T analysis 24-hpf time point highlighted green 3 time points. B, C,                             D, Cell Illustrator Ingenuity pathway analyses used construct pathways significantly regulated transcripts                            6-somite (6S), 20-somite (20S), 24-hpf developmental stages according Cyber-T analysis. right-tailed Fisher exact test <br />                            indicated likelihood pathways constituted random samples 67, 619, 119 transcripts drawn <br />                                                                       Affymetrix microarrays &#226;&#8240;&#165;0.05. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                       Page 21 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                                                              Figure 7. <br />                                FOXO3A IGF signaling NDST1-mediated vasculogenesis.  Graph shows expression FOXO3A transcripts                             differentiating embryoid bodies function time. B, Transcript levels FOXO3A GFP- NDST1-shRNA&#226;&#8364;&#8220;treated <br />                                 cells quantified RT-PCR. C, Western blot showing levels FOXO3A proteins control   NDST1 <br />                               knockdown ES cells. D, Graph shows transcript levels IGF2 NDST1 knockdown ES cells. E, shRNA-mediated <br />                            knockdown FOXO3A resulted downregulation IGF2, indicated IGF2 downstream FOXO3A. shRNA <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                            GFP used control. Data shown mean&#194;&#177;SE 3 independent experiments. **P&lt;0.01, ***P&lt;0.001 vs <br />                             <br /> </body></html>